跳转至内容
Merck

SML0033

Sigma-Aldrich

伊托必利 盐酸盐

≥98% (HPLC)

别名:

N- [ [4- [2-(二甲氨基)乙氧基] 苯基] 甲基]-3,4-二甲氧基苯甲酰胺盐酸盐, N- [p- [2-(二甲氨基)乙氧基] 苄基] 维拉曲米盐酸盐

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C20H26N2O4 ·HCl
分子量:
394.89
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

儲存條件

desiccated

顏色

white to tan

溶解度

H2O: ≥48 mg/mL

起源

Abbott

儲存溫度

2-8°C

SMILES 字串

Cl.COc1ccc(cc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2

InChI

1S/C20H26N2O4.ClH/c1-22(2)11-12-26-17-8-5-15(6-9-17)14-21-20(23)16-7-10-18(24-3)19(13-16)25-4;/h5-10,13H,11-12,14H2,1-4H3,(H,21,23);1H

InChI 密鑰

ZTOUXLLIPWWHSR-UHFFFAOYSA-N

一般說明

盐酸伊托必利是一种新型的促胃肠动力药。

生化/生理作用

伊托必利是乙酰胆碱酯酶 (AChE) 抑制剂和 D2 多巴胺受体拮抗剂。伊托必利是一种促胃动力药。
具有抗胆碱酯酶活性的多巴胺 D2 受体拮抗剂。
盐酸伊托必利通过阻断 D2 受体、突触后胆碱能神经上多巴胺的活性和诱导肌间神经丛中乙酰胆碱的释放,增强胃肠动力。它还能在乙酰胆碱酯酶的帮助下抑制释放的乙酰胆碱的水解。

特點和優勢

该化合物由Abbott开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处

象形圖

Environment

訊號詞

Warning

危險聲明

防範說明

危險分類

Aquatic Acute 1 - Aquatic Chronic 1

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Sanjay Bansal et al.
Drug delivery, 23(2), 437-451 (2014-05-29)
The objectives of present studies were to develop the systematically optimized multiple-unit gastroretentive microballoons, i.e. hollow microspheres of itopride hydrochloride (ITH) employing quality by design (QbD)-based approach. Initially, the patient-centric QTPP and CQAs were earmarked, and preliminary studies were conducted
N Kishibayashi et al.
Japanese journal of pharmacology, 66(4), 397-403 (1994-12-01)
KW-5092 ([1-[2-[[[5-(piperidinomethyl)-2- furanyl]methyl]amino]ethyl]-2-imidazolidinylidene] propanedinitrile fumarate) is a novel gastroprokinetic agent with acetylcholinesterase (AChE) inhibitory activity and acetylcholine release facilitatory activity. The present study used guinea pig ileal homogenates to examine the inhibitory effects of KW-5092 on the activities of AChE
[Effect of HSR-803 on gastrointestinal motility].
H Iwanaga et al.
Nihon Heikatsukin Gakkai zasshi, 25(6), 313-315 (1989-12-01)
Y Iwanaga et al.
Japanese journal of pharmacology, 62(4), 395-401 (1993-08-01)
Stimulatory effects of HSR-803 on intestinal motor activity in vitro were studied in guinea pig ileum. HSR-803 (1 x 10(-6)-1 x 10(-4) M) increased the amplitude of longitudinal muscle contractions and increased the frequency of peristalsis in isolated segments of
Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
Sawant P, et al.
The Journal of the Association of Physicians of India, 52, 626-628 (2004)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门